These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 7814608
1. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. Rubins JB, Charboneau D, Paton JC, Mitchell TJ, Andrew PW, Janoff EN. J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608 [Abstract] [Full Text] [Related]
2. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Rubins JB, Charboneau D, Fasching C, Berry AM, Paton JC, Alexander JE, Andrew PW, Mitchell TJ, Janoff EN. Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1339-46. PubMed ID: 8616564 [Abstract] [Full Text] [Related]
3. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Alexander JE, Berry AM, Paton JC, Rubins JB, Andrew PW, Mitchell TJ. Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638 [Abstract] [Full Text] [Related]
5. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Jounblat R, Kadioglu A, Mitchell TJ, Andrew PW. Infect Immun; 2003 Apr; 71(4):1813-9. PubMed ID: 12654795 [Abstract] [Full Text] [Related]
7. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms. Shak JR, Ludewick HP, Howery KE, Sakai F, Yi H, Harvey RM, Paton JC, Klugman KP, Vidal JE. mBio; 2013 Sep 10; 4(5):e00655-13. PubMed ID: 24023386 [Abstract] [Full Text] [Related]
8. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Harvey RM, Ogunniyi AD, Chen AY, Paton JC. Infect Immun; 2011 Oct 10; 79(10):4122-30. PubMed ID: 21788389 [Abstract] [Full Text] [Related]
9. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. García-Suárez Mdel M, Cima-Cabal MD, Flórez N, García P, Cernuda-Cernuda R, Astudillo A, Vázquez F, De los Toyos JR, Méndez FJ. Infect Immun; 2004 Aug 10; 72(8):4534-40. PubMed ID: 15271913 [Abstract] [Full Text] [Related]
12. Clarithromycin Inhibits Pneumolysin Production via Downregulation of ply Gene Transcription despite Autolysis Activation. Domon H, Isono T, Hiyoshi T, Tamura H, Sasagawa K, Maekawa T, Hirayama S, Yanagihara K, Terao Y. Microbiol Spectr; 2021 Oct 31; 9(2):e0031821. PubMed ID: 34468195 [Abstract] [Full Text] [Related]
13. Role of Pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats. Alcantara RB, Preheim LC, Gentry MJ. Infect Immun; 1999 Jun 31; 67(6):2862-6. PubMed ID: 10338492 [Abstract] [Full Text] [Related]
14. Contributions of pneumolysin, pneumococcal surface protein A (PspA), and PspC to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Ogunniyi AD, LeMessurier KS, Graham RM, Watt JM, Briles DE, Stroeher UH, Paton JC. Infect Immun; 2007 Apr 31; 75(4):1843-51. PubMed ID: 17261599 [Abstract] [Full Text] [Related]
15. Role of platelet-activating factor in pneumolysin-induced acute lung injury. Witzenrath M, Gutbier B, Owen JS, Schmeck B, Mitchell TJ, Mayer K, Thomas MJ, Ishii S, Rosseau S, Suttorp N, Schütte H. Crit Care Med; 2007 Jul 31; 35(7):1756-62. PubMed ID: 17522574 [Abstract] [Full Text] [Related]
16. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model. Benton KA, Paton JC, Briles DE. Microb Pathog; 1997 Oct 31; 23(4):201-9. PubMed ID: 9344781 [Abstract] [Full Text] [Related]
17. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci. Dessing MC, Florquin S, Paton JC, van der Poll T. Cell Microbiol; 2008 Jan 31; 10(1):237-46. PubMed ID: 17711480 [Abstract] [Full Text] [Related]
18. THP-1 monocytes up-regulate intercellular adhesion molecule 1 in response to pneumolysin from Streptococcus pneumoniae. Thornton J, McDaniel LS. Infect Immun; 2005 Oct 31; 73(10):6493-8. PubMed ID: 16177322 [Abstract] [Full Text] [Related]
19. Apigenin protects mice from pneumococcal pneumonia by inhibiting the cytolytic activity of pneumolysin. Song M, Li L, Li M, Cha Y, Deng X, Wang J. Fitoterapia; 2016 Dec 31; 115():31-36. PubMed ID: 27693741 [Abstract] [Full Text] [Related]